Hyponatremia
Serum Na <135 mEq/L; evaluated by volume status and urine osmolality/sodium.
Also known as: hyponatremia, low sodium, SIADH
Overview
Serum sodium concentration <135 mEq/L. Classified by severity (mild 130-134, moderate 125-129, severe <125), acuity (acute <48 h vs chronic), tonicity (hypotonic — true hyponatremia — vs isotonic vs hypertonic pseudohyponatremia), and volume status (hypovolemic, euvolemic, hypervolemic).
Epidemiology
Most common electrolyte abnormality in hospitalized patients (~15-20%). Associated with increased morbidity, mortality, and length of stay across populations.
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Hyponatremia outline — plus all 514 diagnoses, 5,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Risk factors
- Diuretic use, especially thiazides (HCTZ, chlorthalidone)
- SIADH triggers: malignancy (small cell lung), CNS disease (stroke, hemorrhage, infection), pulmonary disease (pneumonia, TB), drugs (SSRIs, carbamazepine, MDMA, antipsychotics)
- Heart failure, cirrhosis, nephrotic syndrome (effective arterial underfilling)
- Adrenal insufficiency, hypothyroidism
- Polydipsia (psychogenic, beer potomania, tea-and-toast)
- Postoperative, hypotonic IV fluid administration
- Exercise-associated hyponatremia (marathon runners over-hydrating with hypotonic fluids)
Pathophysiology
True hypotonic hyponatremia results from excess water relative to sodium. ADH-driven water retention exceeds urinary water excretion capacity. Causes are categorized by volume status: hypovolemic (volume loss replaced with hypotonic fluid), euvolemic (SIADH, hypothyroid, adrenal insufficiency), hypervolemic (HF, cirrhosis, CKD/nephrotic — total body Na increased but water more so). Pseudohyponatremia: severe hyperlipidemia or hyperproteinemia causes lab artifact with normal plasma water Na.
Clinical presentation
Symptoms
- Mild (130-134): often asymptomatic
- Moderate (125-129): nausea, headache, fatigue, gait instability
- Severe (<120 or rapid drop): confusion, seizures, coma, respiratory arrest
- Symptoms more prominent in ACUTE hyponatremia (rapid decrease); chronic patients may tolerate lower levels
Signs / physical exam
- Volume status assessment is central to diagnosis
- Hypovolemic: dry mucous membranes, orthostasis, flat JVP
- Euvolemic: normal volume exam
- Hypervolemic: edema, elevated JVP, ascites, crackles
- Neurologic: altered mental status, focal deficits, hyperreflexia, seizure activity in severe cases
Classic findings
Acute hyponatremia <120 with altered mental status or seizures = emergency requiring 3% hypertonic saline.
Differential diagnosis
- Hypovolemic hyponatremia — Volume depletion + low urine Na (<20) + high urine osm; GI losses, diuretics (high urine Na if active), bleeding
- SIADH (euvolemic) — Normal volume, low serum osm, INAPPROPRIATELY concentrated urine (osm >100), urine Na >40, normal thyroid/adrenal function
- Hypothyroidism / adrenal insufficiency — Test TSH, cortisol; mimic SIADH labs; correct hormone deficit
- Polydipsia / low solute intake — Dilute urine (<100 mOsm/kg), high water intake (psychogenic) or low solute (beer potomania)
- Hypervolemic hyponatremia — Edema, ascites; HF, cirrhosis, nephrotic syndrome; urine Na <20 (except CKD)
- Pseudohyponatremia — Severe hyperlipidemia, hyperproteinemia (multiple myeloma); normal measured osmolality
- Translocational hyponatremia — Hyperglycemia, mannitol; correct Na = measured Na + 1.6 × ((glucose - 100)/100)
Diagnostic workup
Diagnostic criteria
Serum Na <135 + serum osm <275 = true hypotonic hyponatremia. Etiology determined by volume status + urine osmolality + urine Na (algorithmic approach).
Labs
- Confirm true hypotonic hyponatremia: measure serum osmolality (low <275 mOsm/kg in true; normal in pseudohyponatremia; high in hyperglycemia or mannitol)
- Urine osmolality — <100 = primary polydipsia or low solute; >100 = ADH-driven
- Urine sodium — <20 = volume depletion or low effective volume (HF, cirrhosis); >40 = SIADH, salt-wasting, diuretic, adrenal insufficiency
- Volume status assessment (clinical exam)
- TSH, cortisol (or cosyntropin stimulation) to rule out hypothyroidism and adrenal insufficiency
- BMP for renal function, glucose; uric acid (low in SIADH, high in cerebral salt wasting)
Imaging
- Chest CT if SIADH suspected to evaluate for malignancy (especially small cell lung)
- Brain MRI if CNS process suspected as cause
Diagnostic algorithm
flowchart TD A[Serum Na <135] --> B[Serum osmolality] B -->|Normal/High| C[Pseudohyponatremia<br/>or hyperglycemia/mannitol] B -->|Low <275| D[True hypotonic<br/>hyponatremia] D --> E[Assess volume status] E -->|Hypovolemic| F[Urine Na] F -->|<20| G[Extrarenal loss<br/>GI, skin, blood] F -->|>40| H[Renal loss<br/>diuretic, adrenal insuff] E -->|Euvolemic| I[Urine osm] I -->|<100| J[Primary polydipsia<br/>low solute] I -->|>100| K[SIADH, hypothyroid,<br/>adrenal insuff] E -->|Hypervolemic| L[HF, cirrhosis,<br/>nephrotic, CKD]
Treatment
First-line
- Severe symptomatic (seizures, coma, focal neuro deficits):
- 3% hypertonic saline 100 mL IV bolus, may repeat × 2 every 10 min until symptoms improve; goal is +4-6 mEq/L rise to relieve symptoms
- Maximum correction 8-10 mEq/L per 24 h (some experts allow up to 12 mEq/L); slower in chronic, malnourished, alcoholic, or hypokalemic patients to avoid osmotic demyelination
- Treat underlying cause once stable
- Hypovolemic hyponatremia: isotonic saline (normal saline or lactated Ringer's)
- Euvolemic hyponatremia (SIADH): fluid restriction (<800-1000 mL/day) first-line; salt tablets or urea if persistent
- Hypervolemic hyponatremia: fluid + sodium restriction; loop diuretic (furosemide, torsemide); treat underlying HF or cirrhosis
- Stop offending medications (thiazides, SSRIs)
Second-line / adjunct
- Vasopressin receptor antagonists (vaptans): tolvaptan (oral), conivaptan (IV) — for refractory SIADH or hypervolemic hyponatremia; monitor closely due to risk of rapid correction
- Demeclocycline (induces nephrogenic DI) — historical SIADH therapy, rarely used now
- Treat underlying cause: replace cortisol/thyroid hormone, treat malignancy, manage HF/cirrhosis
- If overcorrection occurs (Na rises >10-12 mEq/L in 24 h): re-lower with D5W ± DDAVP to prevent osmotic demyelination
Complications
- Osmotic demyelination syndrome (formerly central pontine myelinolysis) — from overly rapid correction; presents days later with dysarthria, dysphagia, paraparesis, locked-in syndrome; irreversible
- Cerebral edema and herniation from severe acute hyponatremia
- Seizures
- Falls and fractures (chronic mild hyponatremia)
- Increased mortality in hospitalized patients
PANCE pearls
- First step in hyponatremia evaluation: check serum osmolality. Low (<275) = true hypotonic; normal = pseudohyponatremia; high = translocational (hyperglycemia, mannitol).
- SIADH diagnostic criteria: hypotonic hyponatremia + euvolemia + urine osm >100 + urine Na >40 + normal thyroid and adrenal function + no diuretics.
- Correct chronic hyponatremia SLOWLY: max 8-10 mEq/L per 24 hours to avoid osmotic demyelination syndrome. Higher-risk patients (alcoholics, malnourished, hypokalemic): even more cautious.
- Acute symptomatic hyponatremia (<48 h): 3% hypertonic saline is appropriate emergency treatment regardless of chronicity concerns.
- Pseudohyponatremia clue: normal serum osmolality despite low measured Na (lab artifact from hypertriglyceridemia, hyperproteinemia).
- Hyperglycemia correction formula: corrected Na = measured Na + 1.6 × ((glucose − 100)/100). Each 100 mg/dL glucose rise lowers Na ~1.6 mEq/L.
References
- European Society 2014 — Clinical practice guideline on diagnosis and treatment of hyponatraemia (Spasovski et al., Eur J Endocrinol 2014)
- Expert Panel 2013 — Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations (Verbalis et al., Am J Med 2013)
Practice Renal/Urology questions on FirstPassPA
Turn this outline into retention. 5,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Browse all 514 diagnosesEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.